July 17, 2009 - TeraRecon is highlighting its goal to meet the mission of SCCT’s recently-released reporting guidelines for interpreting and reporting coronary CTA, by augmenting the workflow and reporting capabilities of Aquarius iNtuition 4.4 software to achieve increased productivity and enhanced compliance.

July 16, 2009 - Agfa HealthCare said today it expanded the capabilities of its IMPAX Cardiovascular (IMPAX CV) with advanced software for cardiology outcomes management from Cedaron Medical.

July 16, 2009 – Cook Medical received clearance today from the FDA to market its newest balloon dilatation catheter, the Advance 35LP, which is intended for use in patients with lesions in the femoral, iliac and renal arteries.

July 16, 2009 – Boston Scientific Corp. today said its received approval from the FDA to market its TAXUS Liberte Long Paclitaxel-Eluting Coronary Stent System designed for long lesions.

July 15, 2009 - TeraRecon Inc., a developer of imaging processing technology, decision support and 3D visualization solutions, appointed of Dr. TieCheng “TC” Zhao, Ph.D. as vice president of engineering to lead TeraRecon’s engineering team into the next great wave of innovation.

July 15, 2009 – Royal Philips said today it reached an agreement to acquire the assets of InnerCool Therapies Inc., a pioneer in the field of therapeutic hypothermia.

July 15, 2009 - GE Healthcare partnered with Medicalis, a provider of clinical decision support for diagnostic imaging (CDS-DI), to help drive quality healthcare and reduce unnecessary imaging procedures and costs.

July 14, 2009 – The Electronic Health Records Association (EHR Association) made specific recommendations to the Office of the National Coordinator for Health Information Technology (ONC) on measurable criteria for achieving "meaningful use" of EHRs, as called for in the American Recovery and Reinvestment Act of 2009 (ARRA).

July 14, 2009 – Despite the fact that drug-eluting stent (DES) implantation reduces restenosis and the need for target vessel revascularization (TVR), these stents appear to be associated with unfavorable long-term outcomes in patients with moderate or severe renal insufficiency (RI), according to a study in this week’s issue of the International Journal of Cardiology, Volume 136, Issue 1, pag

Subscribe Now